Anebulo Pharmaceuticals, Inc.
NASDAQ:ANEB
1.895 (USD) • At close October 29, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 3.094 | 5.147 | 6.645 | 8.521 | 11.247 | 14.165 | 16.355 | 19.214 | 14.548 | 16.548 | 18.009 | 19.208 | 19.986 | 3.307 | 2.48 | -3.025 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.05 |
Cash and Short Term Investments
| 3.094 | 5.147 | 6.645 | 8.521 | 11.247 | 14.165 | 16.355 | 19.214 | 14.548 | 16.548 | 18.009 | 19.208 | 19.986 | 3.307 | 2.48 | 3.025 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.023 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0 | 0.224 | 0.172 | 0.527 | 0.423 | 0.268 | 0.533 | 0.602 | 1.031 | 0.701 | 0.955 | 1.293 | 1.668 | 0.569 | 0.029 | 0 |
Total Current Assets
| 3.508 | 5.371 | 6.816 | 9.048 | 11.67 | 14.433 | 16.888 | 19.815 | 14.548 | 17.248 | 18.964 | 20.5 | 19.986 | 3.899 | 2.509 | 3.025 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.565 | 0.625 | 0.685 | 0 | 0.423 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.668 | 0.393 | 0.102 | -3.025 |
Total Non-Current Assets
| 0.565 | 0.625 | 0.685 | 0 | 0.423 | 0 | 0 | 0 | 1.031 | 0 | 0 | 0 | 1.668 | 0.393 | 0.102 | -3.025 |
Total Assets
| 4.073 | 5.996 | 7.501 | 9.048 | 11.67 | 14.433 | 16.888 | 19.815 | 15.579 | 17.248 | 18.964 | 20.5 | 21.653 | 4.291 | 2.611 | 0 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 0.156 | 0.385 | 0.319 | 0.566 | 0.535 | 0.571 | 0.347 | 0.523 | 0.381 | 0.083 | 0.043 | 0.494 | 0.11 | 0.082 | 0.084 | 0 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.209 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 0.104 | 0.625 | 0.695 | 0.151 | 0.534 | 0.92 | 1.026 | 0.175 | 0.132 | 0.003 | 0.007 | 0.114 | 0.132 | 0.211 | 0.06 | 0 |
Total Current Liabilities
| 0.261 | 1.01 | 1.014 | 0.717 | 1.069 | 1.491 | 1.372 | 0.698 | 0.513 | 0.086 | 0.05 | 0.608 | 0.242 | 0.293 | 0.354 | 0 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0.625 | 0.695 | 0.151 | 0.534 | 0.571 | 1.026 | 0 | 0 | 0.083 | 0.043 | 0 | 0.11 | 13.434 | 2.976 | 0 |
Total Non-Current Liabilities
| 0 | 0.625 | 0.695 | 0.151 | 0.534 | 0.571 | 1.026 | 0 | 0.381 | 0.083 | 0.043 | 0.494 | 0.11 | 13.434 | 2.976 | 0 |
Total Liabilities
| 0.261 | 1.01 | 1.014 | 0.717 | 1.069 | 1.491 | 1.372 | 0.698 | 0.513 | 0.086 | 0.05 | 0.608 | 0.242 | 13.727 | 3.33 | 0 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.653 | 2,975.752 | 2.976 | 2.976 |
Common Stock
| 0.026 | 0.026 | 0.026 | 0.026 | 0.026 | 0.026 | 0.026 | 0.026 | 0.023 | 0.023 | 0.023 | 0.023 | 0.023 | 0.013 | 0.013 | 0 |
Retained Earnings
| -65.404 | -64.054 | -62.4 | -59.683 | -57.202 | -54.706 | -51.908 | -48.082 | -45.47 | -43.147 | -41.27 | -40.197 | -38.644 | -9.532 | -0.768 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | -0 | -2,975.752 | -0 | -0.171 |
Other Total Stockholders Equity
| 69.19 | 69.013 | 68.862 | 67.989 | 67.778 | 67.622 | 67.399 | 67.173 | 60.513 | 60.286 | 60.161 | 60.067 | 38.379 | 0.084 | -2.94 | 0 |
Total Shareholders Equity
| 3.813 | 4.985 | 6.487 | 8.331 | 10.601 | 12.942 | 15.516 | 19.117 | 15.067 | 17.163 | 18.914 | 19.893 | 21.412 | -9.436 | -0.719 | 2.805 |
Total Equity
| 3.813 | 4.985 | 6.487 | 8.331 | 10.601 | 12.942 | 15.516 | 19.117 | 15.067 | 17.163 | 18.914 | 19.893 | 21.412 | -9.436 | -0.719 | 2.805 |
Total Liabilities & Shareholders Equity
| 4.073 | 5.996 | 7.501 | 9.048 | 11.67 | 14.433 | 16.888 | 19.815 | 15.579 | 17.248 | 18.964 | 20.5 | 21.653 | 4.291 | 2.611 | 2.805 |